AngioDynamics
ANGO
153 hedge funds and large institutions have $377M invested in AngioDynamics in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 52 increasing their positions, 55 reducing their positions, and 19 closing their positions.
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
5.18% more ownership
Funds ownership: 88.12% → 93.31% (+5.2%)
3% more funds holding
Funds holding: 148 → 153 (+5)
5% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 55
20% less capital invested
Capital invested by funds: $475M → $377M (-$97.1M)
27% less call options, than puts
Call options by funds: $128K | Put options by funds: $175K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.36M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.77M |
| 3 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$6.56M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.88M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.4M |
| 2 |
Millennium Management
New York
|
-$9.88M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$7.99M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$5.39M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$5.04M |
ANGO Hedge Fund Activity: Q1 2023 in Review
153 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2023, worth a combined $377M — down 20% from $475M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ANGO positions and 19 closed out — a net gain of 7 holders — while 52 added to existing stakes and 55 trimmed.
The largest buyer was BlackRock, adding an estimated $7.36M. The largest seller was Balyasny Asset Management, cutting an estimated $11.4M.
- 153 institutional investors held AngioDynamics (ANGO) as of Q1 2023, up from 148 in Q4 2022.
- Funds reported $377M of AngioDynamics stock for Q1 2023, down 20% quarter-over-quarter.
- 26 funds opened new AngioDynamics positions in Q1 2023 and 19 closed out, a net change of +7 holders.
- The largest AngioDynamics buyer in Q1 2023 was BlackRock, an estimated $7.36M added.
- The largest AngioDynamics seller in Q1 2023 was Balyasny Asset Management, an estimated $11.4M sold.
Based on aggregated 13F filings for Q1 2023.